Main content

Is the era of the cancer vaccine upon us?

This week Merck (known as MSD in Europe) and Moderna announced that a personalised cancer vaccine had significantly improved the outcomes of melanoma patients.

This week Merck (known as MSD in Europe) and Moderna announced that a personalised cancer vaccine had significantly improved the outcomes of melanoma patients. Is the era of the cancer vaccine, at last, upon us? What does that mean? Anne Willis, a cancer cell biologist at the Medical Research Council, joins us to discuss.

In just a few weeks the Royal Society will be putting out the red carpet as the most coveted prize in non-fiction science is about to be awarded. We will be speaking weekly to the shortlisted authors for the Royal Society Trivedi Book Prize, and we are starting with Kit Chapman, author of the Age of Alchemy.

Plus, Penny Sarchet has, like an alchemist of old, been scouring the most obscure texts and journals to bring us the latest science knowledge.

Presenter: Tom Whipple
Producers: Alex Mansfield, Tabitha Taylor Buck, Katie Tomsett, Keiran Manetta-Jones
Editor: Ilan Goodman
Production Co-ordinator: Jana Bennett-Holesworth

Available now

27 minutes

Featured

  • .

Broadcasts

  • Thu 20 Aug 202616:30
  • Thu 20 Aug 202620:32
  • Fri 21 Aug 202605:32
  • Fri 21 Aug 202609:32
  • Fri 21 Aug 202613:32
  • Last Sunday04:32
  • Last Monday00:32
  • Last Monday20:30
  • Wednesday05:04

Explore further with The Open University

Explore further with The Open University

Discover more fascinating science content with The Open University

Podcast